Andexanet Alfa for Bleeding with Factor Xa Inhibitors

被引：4
|
作者：
Tomoda, Haruo [1 ]
机构：
[1] Tokyo Heart Inst, Tokyo, Japan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 381卷 / 02期
关键词：
REVERSAL; ANTICOAGULATION;
D O I：
10.1056/NEJMc1906058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [21] Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors
    Goldin, Mark
    Smith, Kolton
    Koulas, Ioannis
    Leung, Tungming
    Ravi, Mayuri
    Parhar, Sanjit
    Shah, Sejal
    Floyd, Kayla
    Ohanesian, Lori
    Bain, Rachel
    Defonte, Daniella
    Ochani, Kanta
    Lin, Amanda
    Patel, Bhumi
    Tsaftaridis, Nikolaos
    Jnani, Jack
    Spyropoulos, Alex C.
    TH OPEN, 2024, 08 (02) : e209 - e215
  • [22] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298
  • [23] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
    Siegal, Deborah M.
    Curnutte, John T.
    Connolly, Stuart J.
    Lu, Genmin
    Conley, Pamela B.
    Wiens, Brian L.
    Mathur, Vandana S.
    Castillo, Janice
    Bronson, Michele D.
    Leeds, Janet M.
    Mar, Florie A.
    Gold, Alex
    Crowther, Mark A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2413 - 2424
  • [24] REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES
    Bradshaw, Paige
    Philpott, Carolyn
    Droege, Christopher
    Droege, Molly
    Ernst, Neil
    Foertsch, Madeline
    Harger, Nicole
    Srinivasan, Vasisht
    Winter, Jessica
    Keegan, Shaun
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 450 - 450
  • [25] A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA)
    Rogers, Kelly C.
    Finks, Shannon W.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (01): : 38 - 41
  • [26] RISK FACTORS FOR THROMBOISCHEMIC COMPLICATIONS AFTER ANDEXANET ALFA REVERSAL OF FACTOR XA INHIBITORS
    Bradshaw, Paige
    Shouse, Tiffany
    Foertsch, Madeline
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [27] Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
    Rauch, Sebastian
    Mueller, Hans-Peter
    Dreyhaupt, Jens
    Ludolph, Albert C.
    Kassubek, Jan
    Althaus, Katharina
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [28] Andexanet Alfa Corrects the Interference of Direct Factor Xa Inhibitors on Lupus Anticoagulant Testing
    Baker, Ross I.
    Gilmore, Grace
    McGregor, Scott
    BLOOD, 2016, 128 (22)
  • [29] REVERSAL OF FACTOR XA INHIBITORS-INDUCED ANTICOAGULATION IN HEALTHY SUBJECTS BY ANDEXANET ALFA
    Crowther, Mark
    Lu, Genmin
    Conley, Pamela
    Leeds, Janet
    Castillo, Janice
    Levy, Gallia
    Connolly, Stuart
    Curnutte, John
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [30] Evaluation of oral factor Xa inhibitor-associated extracranial bleeding reversal with andexanet alfa
    Nederpelt, Charlie J.
    Naar, Leon
    Sylvester, Katelyn W.
    Barra, Megan E.
    Roberts, Russel J.
    Velmahos, George C.
    Kaafarani, Haytham M. A.
    Rosenthal, Martin G.
    King, David R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) : 2532 - 2541
12345